Cysteine-rich granulin-3 rapidly promotes amyloid-β fibrils in both redox states

Granulins (GRNs 1-7) are cysteine-rich proteolytic products of progranulin (PGRN) that have recently been implicated in neurodegenerative diseases including frontotemporal dementia (FTD) and Alzheimer's disease (AD). Their precise mechanism in these pathologies remains uncertain, but both inflammatory and lysosomal roles have been observed for GRNs. Among the seven GRNs, GRN-3 is well characterized and is implicated within the context of FTD. However, the relationship between GRN-3 and amyloid-beta (A beta), a protein relevant in AD pathology, has not yet been explored. To gain insight into this mechanism, we investigated the effect of both oxidized and reduced GRN-3 on A beta aggregation and found that both GRN-3 (oxidized) and rGRN-3 (reduced) bind to monomeric and oligomeric A beta 42 to promote rapid fibril formation with subtle rate differences. As low molecular weight oligomers of A beta are well-established neurotoxins, rapid promotion of fibrils by GRN-3 mitigates A beta 42-induced cellular apoptosis. These data provide valuable insights in understanding GRN-3's ability to modulate A beta-induced toxicity under redox control and presents a new perspective toward AD pathology. These results also prompt further investigation into the role(s) of other GRNs in AD pathogenesis.